About InterVenn
InterVenn is a company based in San Francisco (United States) founded in 2017.. InterVenn has raised $250.9 million across 6 funding rounds from investors including SoftBank Group, Genoa Ventures and Heritage Provider Network. InterVenn offers products and services including GlycoVision and Liquid Biopsy Platform. InterVenn operates in a competitive market with competitors including Miroculus, Geneoscopy, HalioDx, Magentiq Eye and AcuamarkDx, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$250.9 M (USD)
in 6 rounds
-
Latest Funding Round
-
Investors
SoftBank Group
& 10 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of InterVenn
InterVenn offers a comprehensive portfolio of products and services, including GlycoVision and Liquid Biopsy Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for analyzing glycoprotein structures in precision medicine.
Tool for detecting diseases through glycoproteome insights.
Unlock access to complete
Unlock access to complete
Funding Insights of InterVenn
InterVenn has successfully raised a total of $250.9M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Last Round
-
First Round
First Round
(03 Oct 2018)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2022 | Amount | Series C - InterVenn | Valuation | Genoa Ventures |
|
| Aug, 2021 | Amount | Series C - InterVenn | Valuation | SoftBank Group , Heritage Provider Network | |
| Nov, 2020 | Amount | Series B - InterVenn | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in InterVenn
InterVenn has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include SoftBank Group, Genoa Ventures and Heritage Provider Network. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage VC firm focused on life science startups
|
Founded Year | Domain | Location | |
|
Early-stage startups are invested in by sector-agnostic VC fund.
|
Founded Year | Domain | Location | |
|
Technical founders are supported through early-stage venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by InterVenn
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - InterVenn
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Intervenn Comparisons
Competitors of InterVenn
InterVenn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Miroculus, Geneoscopy, HalioDx, Magentiq Eye and AcuamarkDx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
MicroRNA profiling platform is developed to detect genes in samples.
|
|
| domain | founded_year | HQ Location |
Non-invasive biomarker tests for colorectal cancer are developed.
|
|
| domain | founded_year | HQ Location |
Developer of diagnostic product for colon cancer
|
|
| domain | founded_year | HQ Location |
Computer vision software is utilized for endoscopic medical procedures.
|
|
| domain | founded_year | HQ Location |
Non-invasive screening tests for early cancer detection are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Intervenn
Frequently Asked Questions about InterVenn
When was InterVenn founded?
InterVenn was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is InterVenn located?
InterVenn is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of InterVenn?
Andrew Quong is the current CEO of InterVenn.
Is InterVenn a funded company?
InterVenn is a funded company, having raised a total of $250.9M across 6 funding rounds to date. The company's 1st funding round was a Series B of $34M, raised on Oct 03, 2018.
What does InterVenn do?
Provider of an AI-based clinical decision supporting tool for cancer detection and drug development. The company has developed tools like Dawn which is immune-oncology testing software that uses glycoproteomics and AI. The VISTA tool assists with the quantification of proteins in serum or blood. It has features to analyze clinical biomarkers for disease diagnosis, drug development, and treatment prediction. The VOCAL is a diagnostic tool for detecting cancer in ovaries.
Who are the top competitors of InterVenn?
InterVenn's top competitors include Geneoscopy, AcuamarkDx and Miroculus.
What products or services does InterVenn offer?
InterVenn offers GlycoVision and Liquid Biopsy Platform.
Who are InterVenn's investors?
InterVenn has 11 investors. Key investors include SoftBank Group, Genoa Ventures, Heritage Provider Network, Irving Investors, and Amplify Partners.